subject: UNII:DPT0O3T46P

object_name: salivary gland carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: salivary gland cancer

tested_intervention: yes


subject: UNII:DPT0O3T46P

object_name: carcinoma of parotid gland


subject: UNII:DPT0O3T46P

object_name: parotid gland cancer


subject: UNII:DPT0O3T46P

object_name: anal margin carcinoma


subject: CHEBI:64816

object_name: Stage IV adult soft tissue sarcoma

tested_intervention: unsure


subject: CHEBI:64816

object_name: Stage IVB adult soft tissue sarcoma


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: osteoporosis


subject: UMLS:C3714648

object_name: Encounter due to family history of osteoporosis


subject: UMLS:C3714648

object_name: Osteoporosis, CTCAE 5.0


subject: UMLS:C3714648

object_name: Osteoporosis, CTCAE 3.0


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: UMLS:C3541380


subject: UMLS:C3541380


subject: UMLS:C3541380


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:28384


subject: CHEBI:28384


subject: CHEBI:28384


subject: CHEBI:18067

subject_name: Phylloquinone


subject: CHEBI:18067


subject: CHEBI:18067


subject: CHEBI:18067


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: UMLS:C2936884


subject: UMLS:C2936884


subject: UMLS:C2936884


subject: UNII:MG4M3QB242

subject_name: matuzumab

object_name: lung cancer


subject: UNII:MG4M3QB242

object_name: lung neoplasm


subject: UNII:MG4M3QB242

object_name: lung carcinoma


subject: UNII:MG4M3QB242

object_name: non-small cell lung carcinoma


subject: UMLS:C1328134


subject: UMLS:C1328134


subject: UMLS:C1328134


subject: UMLS:C1328134


subject: UNII:O5ZD2TU2B7

subject_name: Sebetralstat

object_name: hereditary angioedema


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Marinesco-Sjogren syndrome


subject: UNII:2S9ZZM9Q9V

object_name: Microsatellite Stable


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Rotator cuff tear arthropathy


subject: CHEBI:5103

subject_name: Flumazenil

object_name: liver cirrhosis


subject: CHEBI:5103

object_name: hepatic encephalopathy


subject: CHEBI:44915

subject_name: Propofol

object_name: lung disorder


subject: CHEBI:6931

subject_name: Midazolam


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Progesterone Receptor Positive


subject: UNII:28X28X9OKV

object_name: Estrogen Receptor Positive


subject: UNII:28X28X9OKV

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: no feeling or sensation of skin


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Childhood Breast Carcinoma


subject: CHEBI:201431

object_name: breast carcinoma


subject: CHEBI:201431

object_name: breast cancer


subject: CHEBI:201431

object_name: primary peritoneal carcinoma


subject: CHEBI:201431

object_name: Primary Peritoneal Cancer


subject: CHEBI:201431

object_name: fallopian tube carcinoma


subject: CHEBI:201431

object_name: fallopian tube cancer


subject: CHEBI:201431

object_name: ovarian cancer


subject: CHEBI:201431

object_name: ovarian neoplasm


subject: CHEBI:201431

object_name: ovarian carcinoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:6888


subject: UNII:43K1W2T1M6

subject_name: Interferon alfa-2b

object_name: liver carcinoma


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: pulmonary alveolar proteinosis


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: CHEBI:71255

subject_name: Asenapine

object_name: schizoaffective disorder


subject: CHEBI:71255

object_name: schizophrenia 18


subject: CHEBI:71256

subject_name: (R,R)-asenapine


subject: CHEBI:71256


subject: UNII:JSV288Q5CV

subject_name: Famtozinameran

object_name: SARS (Disease)


subject: UNII:JSV288Q5CV

object_name: SARS-CoV-2 acute respiratory disease


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: ischemia


subject: UMLS:C4733371

subject_name: Kiacta

object_name: amyloidosis


subject: UNII:5X0D9H16IU

subject_name: EPRODISATE DISODIUM


subject: UMLS:C1880542

subject_name: Eprodisate Disodium


subject: CHEBI:48843

subject_name: sodium selenite

object_name: contact exposure to arsenic (history)


subject: CHEBI:48843

object_name: Arsenic Exposure


subject: CHEBI:48843

object_name: Arsenic Poisoning


subject: CHEBI:48843

object_name: Arsenical keratosis


subject: UMLS:C1659520

subject_name: chlorpheniramine / codeine

object_name: inflammatory skin disease


subject: UMLS:C1659520

object_name: dermatitis


subject: UMLS:C1659520

object_name: Dermatitis


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Kidney transplant failure and rejection


subject: CHEBI:9927

subject_name: Valsartan

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:9927

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:9927

object_name: morbid obesity


subject: CHEBI:29002

object_name: Constipation


subject: CHEBI:29002

object_name: Constipation, CTCAE


subject: CHEBI:28972

subject_name: (R)-Propylene glycol


subject: CHEBI:28972


subject: CHEBI:16997

subject_name: Propylene glycol


subject: CHEBI:16997


subject: CHEBI:149504

object_name: type 2 diabetes mellitus


subject: CHEBI:149504

object_name: Insulin resistance


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Chronic uremia


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: euthyroid Graves orbitopathy


subject: CHEBI:73604

object_name: endocrine exophthalmos


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Laryngospasm


subject: CHEBI:9130

object_name: Laryngospasm, CTCAE


subject: CHEBI:77590

subject_name: Armodafinil

object_name: Lewy Bodies


subject: CHEBI:31859

subject_name: Modafinil


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: Stage III Mucosal Melanoma of the Head and Neck AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IVA Mucosal Melanoma of the Head and Neck AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IVC Mucosal Melanoma of the Head and Neck AJCC v7


subject: UNII:M89N0Q7EQR

object_name: Stage IVB Mucosal Melanoma of the Head and Neck AJCC v7


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: stage IIIB melanoma


subject: UNII:DPT0O3T46P

object_name: stage IIIA melanoma


subject: UNII:DPT0O3T46P

object_name: stage IIIC melanoma


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:3286

subject_name: Cabergoline

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:3286

object_name: Carcinoma breast stage IV


subject: CHEBI:3286

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:3286

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:3286

object_name: Breast cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL3544945

object_name: osteoarthritis, knee


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Striae


subject: PUBCHEM.COMPOUND:23668620

subject_name: amphotericin B, deoxycholate drug combination

object_name: Kala-Azar


subject: UNII:44WG8E9MTU

subject_name: AMPHOTERICIN B DEOXYCHOLATE


subject: PUBCHEM.COMPOUND:72728820

subject_name: Moxidectin

object_name: ocular onchocerciasis


subject: PUBCHEM.COMPOUND:72728820

object_name: loiasis


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Heart Failure, CTCAE


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: heart failure


subject: CHEBI:38545


subject: CHEBI:60799

subject_name: Esketamine

object_name: Childhood Breast Carcinoma


subject: CHEBI:60799

object_name: breast carcinoma


subject: CHEBI:60799

object_name: breast cancer


subject: CHEBI:77032

subject_name: Bromhexine


subject: CHEBI:9241

subject_name: Spironolactone


subject: CHEMBL.COMPOUND:CHEMBL4594385

subject_name: ASTEGOLIMAB

object_name: chronic obstructive pulmonary disease


subject: UMLS:C5417877


subject: CHEBI:8499

subject_name: Propranolol

object_name: seasonal affective disorder


subject: CHEBI:9168

subject_name: Sirolimus

object_name: sarcoidosis


subject: CHEBI:9168

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:9168

object_name: skin sarcoidosis


subject: UNII:B4OQY51WZS

object_name: cystic fibrosis


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab


subject: UMLS:C3641122


subject: PUBCHEM.COMPOUND:135659064

subject_name: Folfox


subject: GTOPDB:9596

subject_name: oleclumab


subject: UNII:5CRY01URYQ

subject_name: OLECLUMAB


subject: UMLS:C4085967

subject_name: Oleclumab


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Childhood Malignant Solid Neoplasm


subject: UMLS:C2346820


subject: UNII:7RPW6SU9SC

object_name: adult lymphoma


subject: UNII:7RPW6SU9SC

object_name: pediatric lymphoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Postoperative cognitive dysfunction


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Bedwetting


subject: PUBCHEM.COMPOUND:2735

object_name: enuresis


subject: PUBCHEM.COMPOUND:2735

object_name: Urinary incontinence of non-organic origin


subject: PUBCHEM.COMPOUND:2735

object_name: Urinary incontinence


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UniProtKB:Q9USH8

subject_name: GLU2B_SCHPO Glucosidase 2 subunit beta (sprot)

object_name: body fat percentage (physical finding)


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: chronic kidney disease


subject: CHEBI:5801

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:5801

object_name: cardiovascular disorder


subject: CHEBI:5801

object_name: Aortic stiffness


subject: CHEBI:5801

object_name: arteriosclerosis disorder


subject: CHEBI:5801

object_name: atherosclerosis


subject: CHEBI:5801

object_name: Inflammation


subject: UMLS:C0017302

subject_name: General anesthetic drugs


subject: UMLS:C3536928

subject_name: General Anesthetic [EPC]


subject: PUBCHEM.COMPOUND:131751561

subject_name: Cyclostenol

object_name: Thumb osteoarthritis


subject: DRUGBANK:DB14276

subject_name: Turmeric


subject: PUBCHEM.COMPOUND:5281767

subject_name: CURCUMIN


subject: PUBCHEM.COMPOUND:66580799

subject_name: Roginolisib

object_name: leukemia


subject: PUBCHEM.COMPOUND:66580799

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:66580799

object_name: B-cell chronic lymphocytic leukemia


subject: PUBCHEM.COMPOUND:66580799

object_name: Refractory Leukemia


subject: PUBCHEM.COMPOUND:66580799

object_name: Recurrent Carcinoma


subject: UNII:6K8FC2TF54

subject_name: ROGINOLISIB


subject: UNII:6K8FC2TF54


subject: UNII:6K8FC2TF54


subject: UNII:6K8FC2TF54


subject: UNII:6K8FC2TF54


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: urinary schistosomiasis


subject: UMLS:C3652932

subject_name: pyronaridine and artesunate drug combination


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: HPV positive oropharyngeal squamous cell carcinoma


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: schizophrenia


subject: UNII:XCR2BZ80N7

subject_name: trastuzumab duocarmazine

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: cervical polyp


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Aspirin-sensitive asthma with nasal polyps


subject: UNII:420K487FSG

object_name: Aspirin-induced asthma


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: acquired hemophilia


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: alcohol withdrawal


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:C0Z095LL72

object_name: Solid Neoplasm


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome


subject: CHEBI:28939

object_name: Adverse Event Associated with Cardiac Arrhythmia


subject: CHEBI:28939

object_name: Arrhythmia


subject: UMLS:C4287710

subject_name: Fluorescent Antibody SGM-101

object_name: metastatic colorectal cancer


subject: UMLS:C4287710

object_name: colon carcinoma


subject: UMLS:C4287710

object_name: colorectal cancer


subject: UMLS:C4287710

object_name: colon cancer


subject: UMLS:C4287710

object_name: pancreatic neoplasm


subject: UMLS:C4287710

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4287710

object_name: malignant pancreatic neoplasm


subject: UMLS:C4287710

object_name: Colorectal cancer recurrent


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide

object_name: rectal carcinoma


subject: UMLS:C1172402

object_name: rectal cancer


subject: UMLS:C1172402

object_name: Childhood Rectal Carcinoma


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UMLS:C2828372


subject: UMLS:C2757070

subject_name: Progesterone [EPC]

object_name: Miscarriage


subject: UMLS:C2757070

object_name: spontaneous abortion


subject: PUBCHEM.COMPOUND:11397705

subject_name: Pemafibrate

object_name: diabetic macular edema


subject: PUBCHEM.COMPOUND:11397705

object_name: diabetic retinopathy


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant

object_name: ovarian cancer


subject: UNII:W0ZE0NT8IF

object_name: ovarian neoplasm


subject: UNII:W0ZE0NT8IF

object_name: ovarian carcinoma


subject: UNII:W0ZE0NT8IF

object_name: triple-negative breast carcinoma


subject: UNII:FOF5155FMZ


subject: UNII:FOF5155FMZ


subject: UNII:FOF5155FMZ


subject: UNII:FOF5155FMZ


subject: UNII:7DT29059VX


subject: CHEBI:33387

subject_name: neptunium atom


subject: CHEBI:33387


subject: CHEBI:33387


subject: CHEBI:33387


subject: CHEBI:53793

subject_name: (4-hydroxy-3-nitrophenyl)acetyl group


subject: CHEBI:53793


subject: CHEBI:53793


subject: CHEBI:53793


subject: CHEBI:73425

subject_name: Asn-Pro


subject: CHEBI:73425


subject: CHEBI:73425


subject: CHEBI:73425


subject: CHEBI:50803

subject_name: nanoparticle


subject: CHEBI:50803


subject: CHEBI:50803


subject: CHEBI:50803


subject: MESH:C058314

subject_name: nucleoprotein, Measles virus


subject: MESH:C058314


subject: MESH:C058314


subject: MESH:C058314


subject: CHEBI:71219

subject_name: Pazopanib

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma


subject: PUBCHEM.COMPOUND:24993045

subject_name: Finerenone

object_name: Hypertension, CTCAE


subject: CHEBI:27241

subject_name: methyl uridin-5-yloxyacetate

object_name: prostate cancer


subject: CHEBI:27241

object_name: prostate neoplasm


subject: CHEBI:73616

subject_name: Met-Val


subject: CHEBI:73616


subject: CHEBI:91594

object_name: Childhood Breast Carcinoma


subject: CHEBI:91594

object_name: breast carcinoma


subject: CHEBI:91594

object_name: breast cancer


subject: UMLS:C0678133

subject_name: Taxol


subject: UMLS:C0678133


subject: UMLS:C0678133


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: inflammatory bowel disease 1


subject: CHEBI:61057

object_name: Crohn disease


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Steroid-dependent nephrotic syndrome


subject: CHEBI:168396

object_name: Nephrotic Syndrome - Frequently Relapsing


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: PUBCHEM.COMPOUND:633097

subject_name: Kenalog

object_name: wet macular degeneration


subject: CHEBI:9667

subject_name: Triamcinolone


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: diabetic peripheral angiopathy


subject: UNII:ZL1R02VT79

object_name: cardiovascular disorder


subject: UNII:ZL1R02VT79

object_name: aneurysm


subject: UNII:306ERL82IR

subject_name: Fexinidazole

object_name: human African trypanosomiasis


subject: UNII:306ERL82IR

object_name: infection by Trypanosoma rhodesiense


subject: CHEBI:71940

subject_name: Tadalafil

object_name: hypotension


subject: CHEBI:71940

object_name: Hypotension, CTCAE


subject: CHEBI:71940

object_name: spinal cord injury


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Dialysis hypotension


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: rectal neoplasm


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:24846132

subject_name: Hetastarch

object_name: Osteonecrosis of hip


subject: UMLS:C0591961

subject_name: Pentaspan


subject: UMLS:C3495434

subject_name: hydroxyethyl starch 130-0.4


subject: UMLS:C3642349

subject_name: Volulyte


subject: UNII:UAG0ANS9HZ

subject_name: Darusentan

object_name: hypertension


subject: UNII:UAG0ANS9HZ

object_name: Hypertension, CTCAE


subject: CHEBI:4471

subject_name: dextromethorphan hydrobromide

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:4471

object_name: Fatigue


subject: CHEBI:4471

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:4471

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146178


subject: CHEBI:146178


subject: CHEBI:146178


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: UMLS:C0006055

subject_name: Botulinum Toxins

object_name: Itchiness


subject: UMLS:C0006055

object_name: Cicatrix, Hypertrophic


subject: UMLS:C4687448

subject_name: Anti-ICOS Agonist Monoclonal Antibody BMS-986226

object_name: neoplasm


subject: UMLS:C4687448

object_name: cancer


subject: UMLS:C4687448

object_name: Primary malignant neoplasm


subject: UMLS:C4687448

object_name: childhood neoplasm


subject: UMLS:C4687448

object_name: neoplastic syndrome


subject: UMLS:C4687448

object_name: cancer or benign tumor


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0305062


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C0039620


subject: UMLS:C5240013

subject_name: Vaccine product containing only Clostridium tetani antigen (medicinal product)


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: UMLS:C5240013


subject: CHEBI:84040

object_name: female infertility


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: CHEBI:58097

object_name: Hypoventilation


subject: CHEBI:17303

subject_name: Morphine


subject: UMLS:C0014822

subject_name: Erythropoietin

object_name: Myelodysplasia


subject: UMLS:C0014822

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0014822

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0014822

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0014822

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C0014822

object_name: chronic myelomonocytic leukemia


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: liver carcinoma


subject: CHEBI:9907

subject_name: ursodiol

object_name: pouchitis


subject: CHEBI:9907

object_name: ulcerative colitis


subject: CHEBI:9907

object_name: inflammatory bowel disease 1


subject: CHEBI:231679

object_name: iris melanoma


subject: CHEBI:231679

object_name: Recurrent Uveal Melanoma


subject: CHEBI:231679

object_name: stage IV intraocular melanoma


subject: CHEBI:231679

object_name: medium/large size posterior uveal melanoma


subject: CHEBI:231679

object_name: ocular melanoma with extraocular extension


subject: CHEBI:231679

object_name: small size posterior uveal melanoma


subject: CHEMBL.COMPOUND:CHEMBL5314366

subject_name: ESOMEPRAZOLE MAGNESIUM

object_name: Erosive esophagitis


subject: CHEMBL.COMPOUND:CHEMBL5314366

object_name: peptic esophagitis


subject: CHEMBL.COMPOUND:CHEMBL5314366

object_name: Gastro-esophageal reflux disease with esophagitis


subject: CHEMBL.COMPOUND:CHEMBL5314366

object_name: Gastroesophageal Reflux Disease, CTCAE


subject: UMLS:C5848556

subject_name: Oral medication (substance)


subject: UMLS:C5848556


subject: UMLS:C5848556


subject: UMLS:C5848556

object_name: Heartburn


subject: UMLS:C5848556


subject: UMLS:C5815609

object_name: dry eye syndrome


subject: UNII:0D21EQAQQA

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: UMLS:C0471183

subject_name: Extemporaneous preparation

object_name: asthma


subject: CHEBI:52763

object_name: hypertension


subject: CHEBI:52763

object_name: Hypertension, CTCAE


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: prostate disorder


subject: UNII:3160WY51LV

subject_name: Bixalomer

object_name: chronic kidney disease


subject: UNII:3160WY51LV

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:4856

subject_name: Esmolol

object_name: Diabetic foot ulcer


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: dystocia


subject: CHEBI:31547

subject_name: Eplerenone

object_name: outcomes general quality of life


subject: CHEBI:31547

object_name: Perceived quality of life


subject: CHEBI:31547

object_name: Good quality of life


subject: CHEBI:31547

object_name: Heart failure with normal ejection fraction


subject: CHEBI:31547

object_name: aortic valve disease 1


subject: CHEBI:31547

object_name: aortic valve calcification


subject: CHEBI:600103

subject_name: daptomycin

object_name: kidney failure


subject: CHEBI:600103

object_name: Renal Failure, CTCAE


subject: UMLS:C4508358

subject_name: ergoferon

object_name: influenza


subject: UMLS:C5670961

subject_name: Copper Cu 64 SAR-bisPSMA

object_name: castration-resistant prostate carcinoma


subject: UMLS:C5708742

subject_name: Copper Cu 67 SAR-bisPSMA


subject: CHEBI:64312

subject_name: Memantine

object_name: bipolar depression


subject: GTOPDB:8323

subject_name: monalizumab

object_name: non-small cell lung carcinoma


subject: UNII:3ZXZ2V0588


subject: UMLS:C3896730


subject: UMLS:C0360686

subject_name: Zinc-containing product in oral dose form

object_name: Genital warts


subject: UMLS:C0360686

object_name: human papilloma virus infection


subject: CHEBI:7726

subject_name: octreotide

object_name: diarrhea


subject: CHEBI:7726

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:7726

object_name: Diarrhea, CTCAE


subject: CHEBI:7726

object_name: HIV infection


subject: PUBCHEM.COMPOUND:165363555

subject_name: Trikafta

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:165363555

object_name: lung disorder


subject: UMLS:C5221269


subject: UMLS:C5221269


subject: CHEBI:94449

subject_name: Glycopyrronium

object_name: neurodevelopmental disorder


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Polypoidal choroidal vasculopathy


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: Muscle spasm


subject: UMLS:C0085297

object_name: Hyperkinesia


subject: UMLS:C0085297

object_name: Rigidity


subject: UMLS:C0085297

object_name: stiff-person syndrome


subject: UMLS:C5392737

object_name: respiratory syncytial virus infectious disease


subject: CHEBI:91333

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:91333

object_name: non-Hodgkin lymphoma


subject: UMLS:C2347618


subject: UMLS:C2347618


subject: UMLS:C5240041

subject_name: Uplizna

object_name: neuromyelitis optica


subject: UMLS:C5240041

object_name: pregnancy related


subject: UMLS:C4549234

object_name: hereditary angioedema


subject: CHEBI:63660

object_name: mucocutaneous lymph node syndrome


subject: CHEBI:63618

subject_name: Pravastatin


subject: UNII:XDE2GOF1JT

subject_name: LUVELTAMAB TAZEVIBULIN

object_name: adult acute myeloid leukemia


subject: UNII:XDE2GOF1JT

object_name: childhood acute myeloid leukemia


subject: UNII:XDE2GOF1JT

object_name: acute myeloid leukemia


subject: UMLS:C4764024

subject_name: Anti-FolRa ADC STRO-002


subject: UMLS:C4764024


subject: UMLS:C4764024


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297763

object_name: Neoplasm Metastasis


subject: DRUGBANK:DB05801


subject: DRUGBANK:DB05801


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:173077


subject: CHEBI:134689

subject_name: Rucaparib


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: metastatic squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: paranasal sinus carcinoma


subject: UNII:28X28X9OKV

object_name: paranasal sinus squamous cell carcinoma


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: cancer


subject: CHEBI:91400

subject_name: Afatinib

object_name: neoplastic syndrome


subject: CHEBI:91400

object_name: childhood neoplasm


subject: CHEBI:91400

object_name: cancer or benign tumor


subject: CHEBI:90936

subject_name: Alectinib


subject: CHEBI:90936


subject: CHEBI:231324

subject_name: alpelisib


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:231324


subject: CHEBI:66910

subject_name: Axitinib


subject: CHEBI:66910


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:77562

subject_name: rac-crizotinib


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:75045

subject_name: Dabrafenib


subject: CHEBI:75045


subject: CHEBI:75045


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:132268

subject_name: Dacomitinib


subject: CHEBI:132268

object_name: neoplasm


subject: CHEBI:132268


subject: CHEBI:132268


subject: CHEBI:132268


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UNII:28X28X9OKV


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:195558

subject_name: Entrectinib


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:195558


subject: CHEBI:232556

subject_name: Erdafitinib


subject: CHEBI:232556


subject: CHEBI:232556


subject: CHEBI:232556


subject: CHEBI:232556


subject: CHEBI:114785

subject_name: Erlotinib


subject: CHEBI:114785


subject: CHEBI:85994

subject_name: Lenvatinib


subject: CHEBI:85994


subject: CHEBI:85994


subject: CHEBI:85994


subject: PUBCHEM.COMPOUND:78162481

subject_name: Lorlatinib


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: PUBCHEM.COMPOUND:78162481


subject: CHEBI:52172

subject_name: Nilotinib


subject: CHEBI:52172


subject: CHEBI:52172


subject: CHEBI:52172


subject: CHEBI:52172


subject: CHEBI:177298


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:85993


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: UNII:6A901E312A


subject: UNII:6A901E312A


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib


subject: UNII:Y6BX7BL23K


subject: UNII:Y6BX7BL23K


subject: UNII:Y6BX7BL23K


subject: UNII:Y6BX7BL23K


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68646


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:230905


subject: CHEBI:230905


subject: CHEBI:134689

subject_name: Rucaparib


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: CHEBI:134689


subject: UNII:CEGM9YBNGD

subject_name: Selpercatinib


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: UNII:CEGM9YBNGD


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: GTOPDB:8313

subject_name: talazoparib


subject: GTOPDB:8313


subject: GTOPDB:8313


subject: UNII:1IJV77EI07

subject_name: Tepotinib


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: UNII:1IJV77EI07


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: CHEBI:63637

subject_name: Vemurafenib


subject: CHEBI:63637


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:66903

subject_name: Vismodegib


subject: CHEBI:66903


subject: CHEBI:7936

subject_name: Paroxetine

object_name: sleep disorder


subject: CHEBI:8364

subject_name: Prazosin


subject: CHEBI:91825

subject_name: Dapt

object_name: coronary thrombosis


subject: UNII:949B9ZMO7M

subject_name: Diaminopropanol tetraacetic acid


subject: PUBCHEM.COMPOUND:6438565


subject: CHEBI:91400

subject_name: Afatinib

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:91400

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: Advanced Urothelial Carcinoma


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: PUBCHEM.COMPOUND:90488848

object_name: adrenocortical insufficiency


subject: PUBCHEM.COMPOUND:90488848

object_name: Adrenal Insufficiency, CTCAE


subject: PUBCHEM.COMPOUND:90488848

object_name: Steroid suppression of ACTH secretion


subject: PUBCHEM.COMPOUND:90488848

object_name: Osteopenia/osteoporosis


subject: PUBCHEM.COMPOUND:90488848

object_name: Osteopenia


subject: GTOPDB:1331

subject_name: ACTH


subject: GTOPDB:1331


subject: GTOPDB:1331


subject: GTOPDB:1331


subject: GTOPDB:1331


subject: UMLS:C3539087

subject_name: ACTH and synthetic analog preparations


subject: UMLS:C3539087


subject: UMLS:C3539087


subject: UMLS:C3539087


subject: UMLS:C3539087


subject: CHEBI:3892

subject_name: Corticotropin


subject: CHEBI:3892


subject: CHEBI:3892


subject: CHEBI:3892


subject: CHEBI:3892


subject: UMLS:C5943246

object_name: asthma


subject: CHEBI:188602

subject_name: Seletracetam

object_name: epilepsy


subject: UMLS:C1879965

subject_name: Immunotoxin CMD-193


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist

object_name: type 1 diabetes mellitus


subject: UMLS:C0521942

object_name: hypoglycemia


subject: UMLS:C0521942

object_name: Blood glucose below reference range (finding)


subject: UMLS:C0521942

object_name: Hypoglycemia, CTCAE


subject: CHEBI:149509


subject: CHEBI:149509


subject: CHEBI:149509


subject: CHEBI:149509


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3347


subject: CHEBI:3347


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate

object_name: Knee Injuries


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:132922

object_name: Myalgia, CTCAE


subject: CHEBI:132922

object_name: Myalgia


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:46195

subject_name: Acetaminophen


subject: CHEBI:46195


subject: CHEBI:15765

subject_name: Levodopa

object_name: post-traumatic stress disorder


subject: CHEBI:15765

object_name: BH4-deficient hyperphenylalaninemia A


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: hyperlipidemia, familial combined, LPL related


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: nasopharyngeal disorder


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage II Lung Cancer AJCC v8


subject: UMLS:C3641122


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: thrombophilia due to thrombin defect


subject: KEGG.COMPOUND:C00374

object_name: Venous thrombosis after immobility


subject: KEGG.COMPOUND:C00374

object_name: neoplasm


subject: CHEBI:88249

subject_name: Mirdametinib

object_name: Cutaneous neurofibroma


subject: CHEBI:88249

object_name: neurofibromatosis 1


subject: CHEBI:88249

object_name: neurofibromatosis type 1


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: skin graft (physical finding)


subject: CHEBI:72296

subject_name: Apixaban

object_name: persistent atrial fibrillation


subject: CHEBI:72296

object_name: Persistent Atrial Fibrillation by ECG Finding


subject: CHEBI:63619

subject_name: Propafenone


subject: CHEBI:63619


subject: CHEBI:3535

subject_name: Cephalexin

object_name: Childhood Breast Carcinoma


subject: CHEBI:3535

object_name: breast carcinoma


subject: CHEBI:3535

object_name: breast cancer


subject: CHEBI:3535

object_name: Malignant neoplasm of female breast


subject: CHEBI:3535

object_name: inherited disease susceptibility


subject: CHEBI:3535

object_name: Genetic Predisposition to Disease


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: CHEBI:3534


subject: UMLS:C3827149

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Invagination


subject: CHEBI:17650

object_name: intussusception


subject: DRUGBANK:DB17302

object_name: plasma cell leukemia


subject: DRUGBANK:DB17302

object_name: plasma cell myeloma


subject: DRUGBANK:DB17302

object_name: Relapse multiple myeloma


subject: DRUGBANK:DB17302

object_name: Plasma cell myeloma recurrent


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: diffuse large B-cell lymphoma


subject: UNII:M89N0Q7EQR

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:M89N0Q7EQR

object_name: primary mediastinal large B-cell lymphoma


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: GTOPDB:12990

subject_name: sintilimab

object_name: triple-negative breast carcinoma


subject: GTOPDB:12990

object_name: Triple-Negative Breast Cancer Finding


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C5390939

subject_name: cedazuridine / decitabine

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5390939

object_name: acute myeloid leukemia


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: UMLS:C4278537

object_name: diabetes mellitus


subject: UMLS:C4278537

object_name: type 1 diabetes mellitus


subject: UMLS:C4278537

object_name: Diabetic peripheral neuropathy


subject: CHEBI:135207

subject_name: Clofedanol

object_name: Platelet aggregation inhibition


subject: CHEBI:15365

subject_name: Aspirin


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: UMLS:C0016004

object_name: ptosis


subject: UMLS:C0016004

object_name: Ecchymosis of eyelid


subject: UMLS:C4733610

object_name: Small cell lung cancer recurrent


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Hepatic Complication


subject: CHEBI:33397

subject_name: lawrencium atom


subject: CHEBI:73528

subject_name: Leu-Arg


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab

object_name: Asymptomatic carotid artery stenosis


subject: PUBCHEM.COMPOUND:76022323

subject_name: Idasanutlin

object_name: Solid Neoplasm


subject: UMLS:C4329617

subject_name: Carbon C 13 Idasanutlin


subject: UMLS:C4329618

subject_name: Carbon C 14 Idasanutlin


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: outcomes general quality of life


subject: UNII:PQX0D8J21J

object_name: Perceived quality of life


subject: UNII:PQX0D8J21J

object_name: Good quality of life


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UNII:S4L4MM20B6

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:176724

subject_name: Etiracetam

object_name: traumatic brain injury


subject: UNII:73HC18Y1LW

subject_name: LEVITIRACETAM


subject: CHEBI:6437

subject_name: Levetiracetam


subject: MESH:D018895

subject_name: Microsatellite Repeats

object_name: plasma cell myeloma


subject: UniProtKB:P12055

subject_name: AADK_STAAU Aminoglycoside 6-adenylyltransferase (sprot)


subject: PR:000029927

subject_name: aminoglycoside 6-adenylyltransferase


subject: CHEBI:33380

subject_name: thulium atom


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: UMLS:C3166394

subject_name: Tm antigen


subject: PR:000002105

subject_name: thrombomodulin


subject: UNII:9F972459OC

subject_name: DOTMP HO-166


subject: UMLS:C4053636

subject_name: EGFR Antagonist Hemay022

object_name: HER2 positive breast carcinoma


subject: UMLS:C1258613

subject_name: oblimersen sodium

object_name: Stage IV Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1258613

object_name: Stage III Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1258613

object_name: Stage II Contiguous Adult Diffuse Large Cell Lymphoma


subject: UMLS:C1258613

object_name: Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma


subject: CHEBI:125628

subject_name: Alisertib

object_name: male reproductive organ cancer


subject: CHEBI:125628

object_name: Malignant neoplasm of lip, oral cavity and pharynx


subject: CHEBI:125628

object_name: Malignant tumor of digestive organ


subject: CHEBI:125628

object_name: Malignant neoplasm of female genital organs


subject: UMLS:C5700342


subject: UMLS:C5700342


subject: UMLS:C5700342


subject: UMLS:C5700342


subject: CHEBI:91450

subject_name: Sapanisertib


subject: CHEBI:91450


subject: CHEBI:91450


subject: CHEBI:91450


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Cervix carcinoma recurrent


subject: UNII:52CMI0WC3Y

object_name: Stage IV Cervical Cancer AJCC v6 and v7


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Cervical Cancer AJCC v6 and v7


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Cervical Cancer AJCC v6 and v7


subject: UNII:52CMI0WC3Y

object_name: cervical adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: cervical adenosquamous carcinoma


subject: UNII:52CMI0WC3Y

object_name: Cervical Squamous Cell Carcinoma, Not Otherwise Specified


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:135005

subject_name: Milnacipran

object_name: Vestibulodynia


subject: CHEBI:135005

object_name: vulvodynia


subject: CHEBI:34741

subject_name: Equol

object_name: Menopause present (finding)


subject: CHEBI:34741

object_name: Menopause


subject: CHEBI:5296

subject_name: Gemfibrozil

object_name: Drug Interactions


subject: UMLS:C2348174


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Metastatic hepatocellular carcinoma


subject: CHEBI:72317

object_name: Unresectable Hepatocellular Carcinoma


subject: PUBCHEM.COMPOUND:9831939

subject_name: Xalacom

object_name: open-angle glaucoma


subject: MESH:C571753


subject: CHEBI:136007

subject_name: methylnaltrexone

object_name: intestinal obstruction


subject: CHEBI:7459

subject_name: Naloxone


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Pneumonia caused by SARS-CoV-2


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE

object_name: Tachycardia by ECG Finding


subject: PUBCHEM.COMPOUND:9800288

object_name: Tachycardia


subject: PUBCHEM.COMPOUND:9800288


subject: PUBCHEM.COMPOUND:9800288

object_name: Dyspnea


subject: PUBCHEM.COMPOUND:9800288

object_name: Dyspnea, CTCAE


subject: PUBCHEM.COMPOUND:9800288

object_name: cardiovascular surgery result: dyspnea


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: CHEBI:6904


subject: UNII:96265TNH2R

subject_name: Gedatolisib

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:96265TNH2R

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:578771

subject_name: Betamethasone 17 Valerate

object_name: atopic eczema


subject: CHEBI:3077

subject_name: Betamethasone


subject: CHEBI:8863

subject_name: Riluzole

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Low back pain


subject: UMLS:C3540792

object_name: Acute Pain


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: pemphigus


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:37956

subject_name: histamine antagonist


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: CHEBI:3561

subject_name: Cetirizine


subject: CHEBI:28887

subject_name: Ofatumumab


subject: UMLS:C1541395


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEMBL.COMPOUND:CHEMBL2108181

subject_name: CHERRY JUICE

object_name: Patellofemoral Pain


subject: UMLS:C4764263

subject_name: Radium bromatum

object_name: Childhood Breast Carcinoma


subject: UMLS:C4764263

object_name: breast carcinoma


subject: UMLS:C4764263

object_name: breast cancer


subject: UMLS:C5417823

object_name: fetal erythroblastosis


subject: CHEBI:51368

subject_name: Lofexidine

object_name: Opiate Withdrawal Syndrome


subject: CHEBI:9943

subject_name: Venlafaxine


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: short bowel syndrome


subject: PUBCHEM.COMPOUND:9831414

object_name: hepatobiliary disorder


subject: PUBCHEM.COMPOUND:9831414

object_name: liver disorder


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: CHEBI:80716

subject_name: aplysiatoxin

object_name: spinal cord injury


subject: PR:000007088

subject_name: autotaxin


subject: PR:000015283

subject_name: serine/threonine-protein kinase SMG1


subject: UniProtKB:F1NEA7

subject_name: DMBX1_CHICK Diencephalon/mesencephalon homeobox protein 1 (sprot)


subject: CHEBI:91512

object_name: Solid Neoplasm


subject: CHEBI:91512

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:3628

subject_name: homoharringtonine


subject: PUBCHEM.COMPOUND:3628


subject: CHEBI:71019

subject_name: omacetaxine


subject: CHEBI:71019


subject: UMLS:C4045875

object_name: HIV infection


subject: UMLS:C3275040

object_name: rheumatoid arthritis


subject: CHEBI:3638

subject_name: Chloroquine

object_name: Coronavinae infectious disease


subject: CHEBI:30145

subject_name: lithium atom


subject: CHEBI:30145

object_name: Cognitive impairment


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: CHEBI:4828

subject_name: Ergothioneine

object_name: mild neurocognitive disorder


subject: CHEBI:4828

object_name: mild cognitive impairment


subject: CHEBI:82677

subject_name: ridaforolimus

object_name: liver failure


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: fibromyalgia


subject: CHEBI:17045

object_name: Central neuropathic pain


subject: CHEBI:64312

subject_name: Memantine

object_name: Drug action (disorder)


subject: CHEBI:64312

object_name: Radiation Syndrome


subject: CHEBI:64312

object_name: radiation-induced disorder


subject: CHEBI:8228

subject_name: Pioglitazone


subject: CHEBI:8228


subject: CHEBI:8228


subject: CHEBI:8228


subject: UNII:67RM91WDHQ

subject_name: Onvansertib

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: UNII:67RM91WDHQ

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: UNII:67RM91WDHQ


subject: UNII:67RM91WDHQ

object_name: Myelodysplastic/Myeloproliferative Neoplasm, Not Otherwise Specified


subject: UNII:67RM91WDHQ

object_name: Recurrent Atypical Chronic Myeloid Leukemia


subject: DRUGBANK:DB19282

subject_name: Lacticaseibacillus rhamnosus

object_name: atopic eczema


subject: UMLS:C5203470

subject_name: Obinutuzumab Liquid Injection


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Retinopathy


subject: UNII:ZL1R02VT79

object_name: Retinopathy, CTCAE


subject: UNII:ZL1R02VT79

object_name: sickle cell disease


subject: UNII:349552KRHK

subject_name: Simendan

object_name: Heart Disease Risk Factors


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:5147

subject_name: Formoterol

object_name: Bronchospasm, Exercise-Induced


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:180653

subject_name: Molnupiravir

object_name: viral disease


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB

object_name: Ewing sarcoma


subject: UMLS:C2744646


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: Malaria, Vivax


subject: MESH:C519882

subject_name: chloroguanil, dapsone drug combination


subject: UMLS:C5441924

object_name: diabetic neuropathy


subject: CHEBI:52172

subject_name: Nilotinib

object_name: systemic sclerosis


subject: UNII:PP0SHH6V16

subject_name: Alirocumab

object_name: ST-elevation myocardial infarction


subject: UNII:PP0SHH6V16

object_name: ST Elevation Myocardial Infarction


subject: UMLS:C3273553

subject_name: Sam68 Modulator CWP232291

object_name: juvenile myelomonocytic leukemia


subject: UMLS:C3273553

object_name: chronic myelomonocytic leukemia


subject: UMLS:C3273553

object_name: Myelodysplasia


subject: UMLS:C3273553

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C3273553

object_name: childhood myelodysplastic syndrome


subject: UMLS:C3273553

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C3273553

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C3273553

object_name: acute myeloid leukemia


subject: UMLS:C3273553

object_name: myelofibrosis


subject: CHEBI:42588

subject_name: Fenretinide

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:42588

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UMLS:C5417877

object_name: chronic rhinosinusitis with nasal polyps


subject: CHEBI:85662

subject_name: Lixisenatide

object_name: gastroparesis


subject: CHEBI:85662

object_name: Gastroparesis, CTCAE


subject: UNII:38EAO245ZX

subject_name: Dutogliptin

object_name: type 2 diabetes mellitus


subject: CHEBI:39112

subject_name: Bosutinib

object_name: Hormone receptor positive breast cancer


subject: CHEBI:39112

object_name: hormone receptor-positive breast cancer


subject: CHEBI:39112

object_name: Carcinoma breast stage IV


subject: CHEBI:39112

object_name: Her2-receptor negative breast cancer


subject: CHEBI:85993

subject_name: Palbociclib


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: Blood Clot


subject: PUBCHEM.COMPOUND:92043599

object_name: thrombosis


subject: PUBCHEM.COMPOUND:92043599

object_name: Thrombosis of blood vessel


subject: PUBCHEM.COMPOUND:92043599

object_name: hypertension


subject: PUBCHEM.COMPOUND:92043599

object_name: Hypertension, CTCAE


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: UMLS:C4287659

subject_name: Hyperpolarized Helium 3

object_name: asthma


subject: UMLS:C4287659

object_name: Chronic obstructive pulmonary disease of horses


subject: UMLS:C4287659

object_name: cystic fibrosis


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: CHEBI:141969

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: CHEBI:141969

object_name: adult acute myeloid leukemia with del(5q)


subject: CHEBI:141969

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: CHEBI:141969

object_name: Untreated Adult Acute Myeloid Leukemia


subject: CHEBI:141969

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:141969

object_name: Adult Acute Myeloid Leukemia in Remission


subject: CHEBI:141969

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: CHEBI:141969

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: CHEBI:141969

object_name: Adult Acute Myelomonocytic Leukemia


subject: CHEBI:141969

object_name: Adult Pure Erythroid Leukemia


subject: CHEBI:141969

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: CHEBI:141969

object_name: adult acute monocytic leukemia


subject: CHEBI:141969

object_name: Adult Acute Monoblastic Leukemia


subject: CHEBI:141969

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: CHEBI:141969

object_name: acute megakaryoblastic leukemia in adult


subject: CHEBI:141969

object_name: Adult Erythroleukemia


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline

object_name: acute myeloid leukemia, t(8;21)(q22; q22.1)


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11


subject: PUBCHEM.COMPOUND:148193

object_name: adult acute myeloid leukemia with del(5q)


subject: PUBCHEM.COMPOUND:148193

object_name: adult acute myeloid leukemia with inv(16)(p13;q22)


subject: PUBCHEM.COMPOUND:148193

object_name: Untreated Adult Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:148193

object_name: recurrent adult acute myeloid leukemia


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Acute Myeloid Leukemia in Remission


subject: PUBCHEM.COMPOUND:148193

object_name: adult acute myeloid leukemia with 11q23 (MLL) abnormalities


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Acute Myeloid Leukemia with Minimal Differentiation


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Acute Myelomonocytic Leukemia


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Pure Erythroid Leukemia


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Acute Myeloid Leukemia with Maturation


subject: PUBCHEM.COMPOUND:148193

object_name: adult acute monocytic leukemia


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Acute Monoblastic Leukemia


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Acute Myeloid Leukemia without Maturation


subject: PUBCHEM.COMPOUND:148193

object_name: acute megakaryoblastic leukemia in adult


subject: PUBCHEM.COMPOUND:148193

object_name: Adult Erythroleukemia


subject: UMLS:C0694951

subject_name: INJECTION, AMPHOTERICIN B, 50 MG ADMINISTERED

object_name: Fuchs' endothelial dystrophy


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:38940

subject_name: Sunitinib


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: lung adenocarcinoma


subject: PR:000012912

subject_name: mitochondrial-processing peptidase subunit beta

object_name: malaria


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: cholangiocarcinoma


subject: UNII:P0GVQ9A4S5

object_name: Homologous Recombination Deficiency


subject: UNII:P0GVQ9A4S5


subject: UNII:P0GVQ9A4S5

object_name: Disseminated Malignant Neoplasm


subject: UNII:P0GVQ9A4S5

object_name: Embolism, Tumor


subject: UNII:P0GVQ9A4S5

object_name: Neoplasm Metastasis


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:177298


subject: CHEBI:176844

subject_name: Niraparib


subject: PUBCHEM.COMPOUND:435949

subject_name: IV

object_name: B-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:435949

object_name: B-cell neoplasm


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:74327


subject: CHEBI:33330

subject_name: scandium atom


subject: CHEBI:33330


subject: PR:000007182

subject_name: erythroid membrane-associated protein


subject: PR:000007182


subject: PR:000050188

subject_name: polymeric immunoglobulin receptor secretory component


subject: PR:000050188


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UMLS:C5455243

subject_name: Camcevi

object_name: central precocious puberty


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Duchenne muscular dystrophy


subject: UMLS:C0021745

subject_name: interferon type II

object_name: pulmonary tuberculosis


subject: UMLS:C3539881

subject_name: gamma-interferon


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: preeclampsia


subject: MESH:D002136

object_name: hypertension


subject: MESH:D002136

object_name: Hypertension, CTCAE


subject: MESH:D002136

object_name: toxemia of pregnancy


subject: MESH:D002136

object_name: cardiovascular disorder


subject: MESH:D002136

object_name: aneurysm


subject: MESH:D002136

object_name: heart disorder


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: CHEBI:60791

subject_name: Xylocard

object_name: Refractory migraine


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:4672

subject_name: Docetaxel

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: sedative; anxiety disorder


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: sleep disorder


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: Fungemia


subject: PUBCHEM.COMPOUND:78357831

object_name: Fungemia, CTCAE


subject: UMLS:C0879264


subject: UMLS:C0879264


subject: UMLS:C1613030

subject_name: Mycamine

object_name: Mycoses


subject: UMLS:C1613030


subject: UMLS:C1613030


subject: CHEMBL.COMPOUND:CHEMBL4297828

object_name: neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4297828

object_name: Tumor Mass


subject: UMLS:C4725109


subject: UMLS:C0767948

object_name: prostate carcinoma


subject: UMLS:C0767948

object_name: prostate cancer


subject: UMLS:C5204688

subject_name: Anti-CTLA-4 Monoclonal Antibody REGN4659

object_name: non-small cell lung carcinoma


subject: CHEBI:4604

subject_name: dimenhydrinate

object_name: post operative nausea and vomiting


subject: CHEBI:49900

subject_name: Arsenous acid

object_name: childhood malignant neoplasm


subject: CHEBI:49900

object_name: Li-Fraumeni syndrome


subject: PUBCHEM.COMPOUND:518740

subject_name: Arsenic trioxide


subject: PUBCHEM.COMPOUND:518740


subject: CHEBI:30621

subject_name: diarsenic trioxide


subject: CHEBI:30621


subject: UNII:S7V92P67HO


subject: UNII:S7V92P67HO


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: Stomach cancer


subject: CHEBI:5847

object_name: gastric cancer


subject: UNII:N5UK68MGDZ

subject_name: Apremilast

object_name: erythema multiforme


subject: UNII:N5UK68MGDZ

object_name: Erythema Multiforme, CTCAE


subject: CHEBI:8107

subject_name: Phenytoin

object_name: Traumatic Wound


subject: CHEBI:8107

object_name: Injury


subject: CHEBI:8107

object_name: Wounds and Injuries


subject: CHEBI:9398

subject_name: Tamsulosin

object_name: bladder tumor


subject: CHEBI:9398

object_name: urinary bladder carcinoma


subject: CHEBI:9398

object_name: urinary bladder cancer


subject: CHEBI:9398

object_name: childhood bladder carcinoma


subject: GTOPDB:8313

subject_name: talazoparib

object_name: Fallopian Tube Serous Neoplasm


subject: GTOPDB:8313

object_name: HER2/Neu Negative


subject: GTOPDB:8313

object_name: ovarian serous tumor


subject: GTOPDB:8313

object_name: Estrogen Receptor Negative


subject: GTOPDB:8313

object_name: Progesterone Receptor Negative


subject: GTOPDB:8313

object_name: ovarian serous adenocarcinoma


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: peripheral vascular disease


subject: CHEBI:22652

object_name: peripheral arterial disease


subject: CHEBI:39548

subject_name: Atorvastatin


subject: CHEBI:74705

subject_name: Met-Leu

object_name: acute coronary syndrome


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:87681

subject_name: Ranolazine

object_name: cardiac conduction defect


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Fanconi anemia


subject: PUBCHEM.COMPOUND:135449332

object_name: Fanconi anemia complementation group A


subject: UNII:VUW370O5QE

subject_name: Cancidas

object_name: Mycoses


subject: UMLS:C1145191

subject_name: INJECTION, CASPOFUNGIN ACETATE, 5 MG


subject: UMLS:C0935942


subject: UMLS:C5781451

subject_name: Cinnamon Extract

object_name: Androgen excess


subject: CHEBI:3023

subject_name: Benzbromarone

object_name: heart failure


subject: CHEBI:3023

object_name: Heart Failure, CTCAE


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Hyperuricemia


subject: UMLS:C0013227

object_name: Hyperuricemia, CTCAE


subject: UMLS:C0013227


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: stage IIIC melanoma


subject: UNII:2S9ZZM9Q9V

object_name: stage IIIB melanoma


subject: CHEBI:79699

subject_name: Temsirolimus


subject: CHEBI:79699


subject: UNII:DTW1NJ7IJH

subject_name: FASEDIENOL

object_name: Adjustment disorder with anxious mood


subject: UMLS:C4305823


subject: UMLS:C0732225

subject_name: Octaplas


subject: MESH:D008458

subject_name: Measles Vaccine

object_name: juvenile idiopathic arthritis


subject: MESH:D009108

subject_name: Mumps Vaccine


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: superficial urinary bladder carcinoma


subject: UMLS:C3896806


subject: UMLS:C2930857

object_name: HIV infection


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: Irritable bowel syndrome with diarrhea


subject: UNII:DWN2WN457X

subject_name: Dexamethasone acetate monohydrate

object_name: hip fracture


subject: PUBCHEM.COMPOUND:3680

subject_name: Dexamethasone acetate


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C5908040

subject_name: Autologous CRISPR-edited Tumor Infiltrating Lymphocytes GT316

object_name: Childhood Solid Neoplasm


subject: UMLS:C5908040

object_name: Adult Solid Neoplasm


subject: UMLS:C5908040

object_name: Solid Neoplasm


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:39548

object_name: Loss of Chromosome 17p


subject: CHEBI:39548

object_name: chromosome 17p deletion


subject: CHEBI:39548

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:39548

object_name: recurrent childhood acute myeloid leukemia


subject: CHEBI:39548

object_name: recurrent adult acute myeloid leukemia


subject: CHEBI:39548


subject: CHEBI:39548

object_name: Recurrent Childhood Acute Lymphoblastic Leukemia


subject: CHEBI:39548

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: CHEBI:39548

object_name: Plasma cell myeloma recurrent


subject: CHEBI:39548

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:39548

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:39548

object_name: Recurrent Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:39548

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:39548

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:39548

object_name: Aggressive Non-Hodgkin Lymphoma


subject: CHEBI:39548

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:39548

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:39548

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:39548

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:39548

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:39548

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:39548

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:39548

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:39548

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:39548

object_name: prolymphocytic leukemia


subject: CHEBI:39548

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:39548

object_name: non-Hodgkin lymphoma


subject: CHEBI:39548

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:39548

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:201431

subject_name: Cyclosporin H

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:201431

object_name: Loss of Chromosome 17p


subject: CHEBI:201431

object_name: chromosome 17p deletion


subject: CHEBI:201431

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:201431

object_name: Recurrent Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:4031

subject_name: Cyclosporine


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: CHEBI:4031


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368

object_name: Aggressive Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Aggressive Adult Non-Hodgkin Lymphoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:6121

subject_name: Ketamine

object_name: sleep apnea


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Recurrent B Acute Lymphoblastic Leukemia, BCR-ABL1-Like


subject: CHEBI:4026

object_name: Refractory B Acute Lymphoblastic Leukemia, BCR-ABL1-Like


subject: CHEBI:4026

object_name: B-lymphoblastic leukemia/lymphoma MLL rearranged


subject: CHEBI:4026

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:4026

object_name: Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:37845

subject_name: growth hormone

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:37845

object_name: amyotrophic lateral sclerosis


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: neuralgia


subject: UMLS:C0085297

object_name: Neuropathic pain


subject: CHEBI:37924

subject_name: Atazanavir

object_name: Coronavinae infectious disease


subject: CHEBI:37924

object_name: Severe acute respiratory infection


subject: CHEBI:37924


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:MLU3LU3EVV

subject_name: Onasemnogene abeparvovec

object_name: spinal muscular atrophy, type 1


subject: UMLS:C5140521

subject_name: onasemnogene abeparvovec-xioi


subject: UNII:8375F9S90C

subject_name: Pamiparib

object_name: cancer


subject: UNII:8375F9S90C

object_name: neoplasm


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:4026

object_name: Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma


subject: CHEBI:4026

object_name: Refractory Grade 3b Follicular Lymphoma


subject: CHEBI:4026

object_name: Recurrent Grade 3b Follicular Lymphoma


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: DRUGBANK:DB16582

subject_name: Lisocabtagene maraleucel


subject: MESH:C000720852

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: MESH:C000720852

object_name: Diffuse large B-cell lymphoma recurrent


subject: MESH:C000720852


subject: MESH:C000720852

object_name: Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified


subject: MESH:C000720852

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: MESH:C000720852

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: MESH:C000720852


subject: MESH:C000720852


subject: MESH:C000720852


subject: CHEBI:28821

subject_name: Piperine

object_name: plasma cell myeloma


subject: CHEBI:28821

object_name: prostate carcinoma


subject: CHEBI:28821

object_name: prostate cancer


subject: CHEBI:28821

object_name: monoclonal gammopathy of uncertain significance


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:28748

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:28748

object_name: Malignant Ovarian Mixed Epithelial Tumor


subject: CHEBI:28748

object_name: ovarian seromucinous carcinoma


subject: CHEBI:28748

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:28748

object_name: ovarian Brenner tumor


subject: CHEBI:28748

object_name: ovarian clear cell cystadenocarcinoma


subject: CHEBI:28748

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:28748

object_name: ovarian serous cystadenocarcinoma


subject: CHEBI:28748

object_name: ovarian mucinous cystadenocarcinoma


subject: UNII:WP6PY72ZH3

subject_name: Motolimod


subject: UNII:WP6PY72ZH3

object_name: Recurrent ovarian cancer


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: UNII:WP6PY72ZH3


subject: DRUGBANK:DB12595

subject_name: Nerinetide

object_name: Ruptured cerebral aneurysm


subject: DRUGBANK:DB12595

object_name: subarachnoid hemorrhage


subject: UMLS:C4519149


subject: UMLS:C4519149


subject: UMLS:C2710997

subject_name: lamotrigine 25 MG Oral Tablet includes 35 Count Pack

object_name: Non dystrophic myotonia


subject: CHEBI:6916

subject_name: Mexiletine


subject: CHEBI:42797

subject_name: Gabapentin

object_name: Fused vertebrae


subject: UMLS:C5706441

subject_name: Anti-B7-H6/Anti-CD3 Bispecific Antibody BI 765049

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5706441

object_name: colorectal carcinoma


subject: UMLS:C5706441

object_name: Stomach cancer


subject: CHEBI:137359

object_name: alcoholic liver diseases


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEBI:45924

subject_name: Trimethoprim

object_name: Infection


subject: CHEBI:45924

object_name: infectious disease


subject: CHEBI:45924

object_name: Adverse Event Associated with Infection


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: plasma cell myeloma


subject: CHEBI:194135

subject_name: Ofloxacin


subject: CHEBI:194135


subject: CHEBI:194135


subject: CHEBI:194135


subject: CHEBI:63598

subject_name: Levofloxacin


subject: UniProtKB:P46842

subject_name: APA_MYCLE Alanine and proline-rich secreted protein Apa (sprot)

object_name: Diabetic foot ulcer


subject: CHEBI:8499

subject_name: Propranolol

object_name: sickle cell disease


subject: CHEBI:135515

subject_name: Bendamustine

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:135515

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UNII:P93RUU11P7


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: CHEBI:63623

subject_name: Succimer

object_name: lead poisoning


subject: UNII:7W3V82OQ0P

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:7W3V82OQ0P

object_name: amyotrophic lateral sclerosis


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: cervical cancer


subject: CHEBI:90001

object_name: cervical carcinoma


subject: CHEBI:28082


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: UMLS:C3813556


subject: PR:000050337

subject_name: mature calcitonin


subject: PR:000050337


subject: UMLS:C4329334

subject_name: Ezabenlimab

object_name: Neoplasm Metastasis


subject: UMLS:C4725787

subject_name: SMAC Mimetic BI 891065


subject: UMLS:C4725787

object_name: non-small cell lung carcinoma


subject: UMLS:C4725787

object_name: neoplasm


subject: DRUGBANK:DB15074

subject_name: Aglatimagene besadenovec

object_name: brain glioma


subject: DRUGBANK:DB15074

object_name: glioblastoma


subject: DRUGBANK:DB15074

object_name: Childhood Glioblastoma


subject: DRUGBANK:DB15074

object_name: adult glioblastoma


subject: CHEBI:465284

subject_name: Ganciclovir


subject: CHEBI:465284


subject: CHEBI:465284


subject: CHEBI:465284


subject: PUBCHEM.COMPOUND:2269

object_name: cellulitis


subject: PUBCHEM.COMPOUND:2269

object_name: skin infection


subject: PUBCHEM.COMPOUND:2269

object_name: Skin Infection, CTCAE


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: preeclampsia


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C5854614

subject_name: BCR Signaling Pathway Inhibitor DZD8586

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C5854614

object_name: non-Hodgkin lymphoma


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: skull base neoplasm


subject: CHEBI:17549

object_name: childhood neoplasm


subject: CHEBI:17549

object_name: neoplastic syndrome


subject: CHEBI:17549

object_name: cancer or benign tumor


subject: CHEBI:17549


subject: UMLS:C3640947

subject_name: HPV E6/E7 DNA Vaccine GX-188E

object_name: head and neck squamous cell carcinoma


subject: CHEBI:45783

subject_name: Imatinib

object_name: prostate neoplasm


subject: CHEBI:23080

subject_name: cerotoyl group

object_name: esophageal squamous cell carcinoma


subject: PR:000015192

subject_name: sodium- and chloride-dependent creatine transporter 1


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Allergy


subject: CHEBI:5134

object_name: hypersensitivity reaction disease


subject: CHEBI:5134

object_name: Emotional hypersensitivity


subject: CHEBI:5134

object_name: type 1 diabetes mellitus


subject: UNII:6I3O3W6O3B

subject_name: Entospletinib

object_name: diffuse large B-cell lymphoma


subject: CHEBI:52717

subject_name: Bortezomib

object_name: rheumatoid arthritis


subject: UNII:CRR8E37XOB

object_name: skin melanoma


subject: UMLS:C1569206


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Head Injury


subject: UMLS:C2934919

object_name: arteriosclerosis disorder


subject: UMLS:C2934919

object_name: atherosclerosis


subject: PUBCHEM.COMPOUND:2269

object_name: Pneumonia caused by SARS-CoV-2


subject: UMLS:C0812732


subject: CHEBI:51254

subject_name: AMOXICILLIN


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:487869

subject_name: clavulanate


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Perioperative complication


subject: CHEBI:3614

object_name: Postoperative Complications


subject: CHEBI:3614

object_name: Pathologic Processes


subject: CHEBI:3614

object_name: no feeling or sensation of skin


subject: CHEBI:3614

object_name: Sensory Loss


subject: CHEBI:6427

subject_name: Leuprolide

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:6427

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:6427

object_name: morbid obesity


subject: UMLS:C3714646

subject_name: Neurobion

object_name: congenital heart disease


subject: UMLS:C3714646

object_name: beriberi


subject: UMLS:C3714646

object_name: Thiamine deficiency


subject: UMLS:C3714646

object_name: Decreased circulating vitamin B1 concentration


subject: PUBCHEM.COMPOUND:25185057

subject_name: lefamulin

object_name: Community-Acquired Pneumonia


subject: CHEBI:84500

subject_name: varenicline

object_name: Fetal anomaly


subject: MESH:C000619755

object_name: Hepatic impairment


subject: UMLS:C4045508

object_name: obesity


subject: UMLS:C4045508

object_name: Overweight


subject: CHEBI:32599

object_name: Pre-eclampsia aggravated


subject: UNII:O9OC34WOAY

subject_name: Osoresnontrine

object_name: schizophrenia


subject: UMLS:C4552090

object_name: Childhood Solid Neoplasm


subject: UMLS:C4552090

object_name: Adult Solid Neoplasm


subject: UMLS:C4552090

object_name: Solid Neoplasm


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Head and neck cancer metastatic


subject: UMLS:C0879636

subject_name: IMC C225


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UNII:KXG2PJ551I

object_name: Recurrent Malignant Head and Neck Neoplasm


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: Non-high-risk proliferative retinopathy due to diabetes mellitus


subject: UMLS:C2352201

subject_name: Conbercept


subject: PUBCHEM.COMPOUND:135436482

subject_name: Calcium folinate

object_name: hereditary spastic paraplegia


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: UMLS:C0936150

subject_name: artemether / lumefantrine

object_name: Plasmodium vivax malaria without complication


subject: CHEBI:8405

subject_name: Primaquine


subject: CHEBI:3638

subject_name: Chloroquine


subject: CHEBI:114785

subject_name: Erlotinib

object_name: Epidermal growth factor receptor positive non-small cell lung cancer


subject: CHEBI:80270

object_name: binge eating


subject: CHEBI:80270

object_name: eating disorder


subject: CHEBI:80270

object_name: Tritanomaly


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PUBCHEM.COMPOUND:52943177


subject: PR:000008039

subject_name: GATA-type zinc finger protein 1


subject: PR:000008039


subject: PR:000008039


subject: UMLS:C0061355

subject_name: Glucagon-Like Peptide 1


subject: UMLS:C0061355


subject: UMLS:C0061355


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: PUBCHEM.COMPOUND:70789204

object_name: Mantle cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Adult Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: anaplastic large cell lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: hepatosplenic T-cell lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: angioimmunoblastic T-cell lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: nodal marginal zone B-cell lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Recurrent Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: splenic marginal zone lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: adult nasal type extranodal NK/T-cell lymphoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204

object_name: Mycosis fungoides/Sezary syndrome recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: Stomach cancer


subject: CHEBI:194095

object_name: gastric cancer


subject: CHEBI:194095

object_name: gastric adenocarcinoma


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:27504


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:32150


subject: CHEBI:132112


subject: CHEBI:132112


subject: CHEBI:132112


subject: UMLS:C1533712

subject_name: Heparanase inhibitor PI-88

object_name: prostate carcinoma


subject: UMLS:C1533712

object_name: prostate cancer


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Lower back injury


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:49960

subject_name: Vandetanib

object_name: Plexosarcoma


subject: CHEBI:134677

subject_name: Crisaborole

object_name: atopic eczema


subject: CHEBI:6931

subject_name: Midazolam

object_name: traumatic encephalopathy


subject: CHEBI:6931

object_name: traumatic brain injury


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: alcohol abuse


subject: CHEBI:6950

object_name: alcohol dependence


subject: CHEBI:49886

subject_name: rimantadine

object_name: hepatitis C


subject: CHEBI:94440

subject_name: Rimantadine


subject: UMLS:C0388088

object_name: Multiple sclerosis relapse


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: follicular lymphoma


subject: PR:000005931


subject: UMLS:C0721051

subject_name: Imovax Rabies

object_name: rabies


subject: UMLS:C5400115

subject_name: Cisplatin Liquid Injection

object_name: nasopharyngeal carcinoma


subject: UMLS:C5400115

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: Stage IV Rectal Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IV Rectal Cancer AJCC v7


subject: UNII:6A901E312A

object_name: Rectal cancer stage IV


subject: UNII:6A901E312A

object_name: Stage IV Rectal Cancer AJCC v6


subject: UNII:6A901E312A

object_name: Recurrent Rectal Cancer


subject: UNII:6A901E312A

object_name: Colon cancer recurrent


subject: UNII:6A901E312A

object_name: Stage IV Colon Cancer AJCC v8


subject: UNII:6A901E312A

object_name: Stage IV Colon Cancer AJCC v6


subject: UNII:6A901E312A

object_name: Stage IV Colon Cancer AJCC v7


subject: UNII:6A901E312A

object_name: Malignant neoplasm of colon stage IV


subject: UNII:6A901E312A

object_name: colon mucinous adenocarcinoma


subject: UNII:6A901E312A

object_name: colon signet ring cell adenocarcinoma


subject: UNII:6A901E312A

object_name: rectal signet ring cell adenocarcinoma


subject: UNII:6A901E312A

object_name: rectum mucinous adenocarcinoma


subject: CHEBI:91872

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:32660

subject_name: asparaginase


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:4911

subject_name: Etoposide


subject: PUBCHEM.COMPOUND:3367


subject: GTOPDB:4934

subject_name: G-CSF


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:8378

subject_name: Prednisolone


subject: PUBCHEM.COMPOUND:34698

subject_name: Teniposide


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:143658


subject: CHEBI:36373

subject_name: vindesine


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: diabetes mellitus, ketosis-prone


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:6801

subject_name: Metformin


subject: UMLS:C0385862

object_name: lymphoproliferative syndrome


subject: UMLS:C0385862

object_name: Kaposi Sarcoma


subject: UMLS:C0385862

object_name: HIV infection


subject: UMLS:C5963214

subject_name: Pan-TEAD Inhibitor ISM6331

object_name: malignant mesothelioma


subject: UMLS:C5963214

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C5963214

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: sinusitis


subject: CHEBI:9667

object_name: Sinusitis, CTCAE


subject: UMLS:C5226598

object_name: EXCESS LMW-DNA


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:1C6V77QF41

object_name: non-Hodgkin lymphoma


subject: UNII:1C6V77QF41

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:1C6V77QF41

object_name: Childhood Non-Hodgkin Lymphoma


subject: UNII:1C6V77QF41

object_name: Untreated Chronic Lymphocytic Leukemia


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:72690

subject_name: Pomalidomide

object_name: Multiple myeloma progression


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Atypical behavior


subject: CHEBI:229764

subject_name: Selinexor

object_name: Coronavinae infectious disease


subject: UNII:Q91187K011

subject_name: Tetraferric tricitrate decahydrate

object_name: chronic kidney disease


subject: CHEBI:144421

subject_name: ferric citrate


subject: HMDB:HMDB0013470

subject_name: LPS with O-antigen

object_name: Ketoacidosis


subject: HMDB:HMDB0013470

object_name: type 1 diabetes mellitus


subject: CHEBI:52603


subject: CHEBI:52603


subject: GTOPDB:5019

subject_name: LPS


subject: GTOPDB:5019


subject: CHEBI:16412

subject_name: Lysophosphotidylserine


subject: CHEBI:16412


subject: CHEBI:89981

subject_name: Endotoxins


subject: CHEBI:89981


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: CHEMBL.COMPOUND:CHEMBL4630622


subject: PR:000001155

subject_name: Toll-like receptor 4


subject: PR:000001155


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: sickle cell disease


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: UMLS:C5553012

subject_name: Anti-CCR7 Monoclonal Antibody CAP-100

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: acute myocardial infarction


subject: CHEBI:169833

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:82814


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:101278


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Metastatic Kidney Carcinoma


subject: UMLS:C2346820


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: nonpapillary renal cell carcinoma


subject: UNII:CWG62Q1VTB

object_name: clear cell renal carcinoma


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB

object_name: Stage III Renal Cell Cancer AJCC v7


subject: UNII:CWG62Q1VTB

object_name: Stage IV Renal Cell Cancer AJCC v7


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: type C thymoma


subject: UMLS:C3827082


subject: UMLS:C2826358

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:240107

subject_name: Bromfenac

object_name: dry eye syndrome


subject: CHEBI:6129

subject_name: Ketorolac


subject: UNII:Y3530Z78QD

object_name: bipolar disorder


subject: UNII:Y3530Z78QD

object_name: bipolar depression


subject: UMLS:C3489799


subject: UMLS:C3489799


subject: UNII:52CMI0WC3Y

object_name: trabecular adenocarcinoma


subject: UNII:52CMI0WC3Y

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:52CMI0WC3Y

object_name: adult lymphoma


subject: UNII:52CMI0WC3Y

object_name: lymphoma


subject: UNII:52CMI0WC3Y

object_name: pediatric lymphoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: small cell lung carcinoma


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026

object_name: Microsatellite Instability


subject: CHEBI:4026

object_name: urothelial carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: HER2 positive breast carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: nonpapillary renal cell carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: clear cell renal carcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: renal cell adenocarcinoma


subject: PUBCHEM.COMPOUND:3367

object_name: renal cell carcinoma


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367

object_name: transitional cell carcinoma


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985

object_name: cervical cancer


subject: GTOPDB:4985

object_name: cervical carcinoma


subject: GTOPDB:4985

object_name: squamous cell carcinoma


subject: GTOPDB:4985

object_name: trabecular adenocarcinoma


subject: GTOPDB:4985

object_name: cutaneous neuroendocrine carcinoma


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: UMLS:C5139755

subject_name: Human interleukin-2


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: UMLS:C5139755


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:3655

subject_name: Chlorzoxazone

object_name: Orofacial Pain


subject: CHEBI:3655

object_name: bruxism


subject: CHEBI:7789

subject_name: Orphenadrine


subject: CHEBI:7789


subject: PR:000006521

subject_name: protein delta homolog 1

object_name: Surgical procedure finding


subject: PR:000006521

object_name: cancer


subject: PR:000006521

object_name: neoplasm


subject: PR:000006521

object_name: Fatigue, CTCAE 5.0


subject: PR:000006521

object_name: Fatigue


subject: UMLS:C2347529

subject_name: Plant-Derived Hematopoiesis Enhancer PG2


subject: UMLS:C2347529


subject: UMLS:C2347529


subject: UMLS:C2347529


subject: UMLS:C2347529


subject: UMLS:C4742269

object_name: influenza


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Stage IV Nasopharyngeal Carcinoma


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:34683

object_name: hypophosphatemia


subject: CHEBI:34683

object_name: Hypophosphatemia, CTCAE


subject: CHEBI:37583

subject_name: trisodium phosphate


subject: CHEBI:37583


subject: CHEBI:132922

object_name: Effects of high altitude


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UMLS:C4507515

object_name: vasculitis


subject: UMLS:C4507515

object_name: Vasculitis, CTCAE


subject: UNII:5RV7T5BNMG

object_name: atopic eczema


subject: DRUGBANK:DB18899


subject: CHEBI:75551


subject: UMLS:C0032140

subject_name: plasminogen

object_name: hypoplasminogenemia


subject: UMLS:C0032140

object_name: ligneous conjunctivitis


subject: CHEBI:73495

subject_name: Glu-Cys-Cys

object_name: Stomach cancer


subject: CHEBI:73495

object_name: gastric cancer


subject: CHEBI:73495

object_name: Neoplasm Metastasis


subject: CHEBI:91985

subject_name: nadolol

object_name: Uncomplicated mild persistent asthma


subject: PUBCHEM.COMPOUND:14794883

subject_name: Folerogenin


subject: CHEBI:4672

subject_name: Docetaxel

object_name: testicular germ cell tumor 1


subject: CHEBI:4672

object_name: testicular germ cell tumor


subject: CHEBI:4672

object_name: childhood testicular germ cell tumor


subject: CHEBI:4672

object_name: extragonadal germ cell tumor


subject: CHEBI:31617

subject_name: fludeoxyglucose (18F)

object_name: hormone-resistant prostate carcinoma


subject: CHEBI:31617

object_name: Metastatic malignant neoplasm to bone


subject: CHEBI:28741

subject_name: Sodium fluoride


subject: CHEBI:28741

object_name: metastatic prostate carcinoma


subject: CHEBI:28741


subject: PUBCHEM.COMPOUND:5066234

subject_name: Sucralose

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:5066234

object_name: obesity


subject: PUBCHEM.COMPOUND:5066234

object_name: Obesity, CTCAE